Please assess the completion status of the following clinical trial:

Trial Title: Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age between 18 and 75 years~* stable angina or silent ischemia~* documented CAD~* signed written informed consent~Exclusion Criteria:~* current or recent therapy (stop \< 3 months) with statins~* allergy to ASA or ticlopidine/clopidogrel~* myocardial infarction (\< 3 months)~* recent significant trauma or surgical interventions (\< 3 mesi)~* significant renal or hepatic diseases~* coagulative-hematological disorders~* cancer~* inflammatory diseases~* myopathy~* pregnancy (a pregnancy test will be performed in fertile women)~* severe coronary calcification, or small vessels disease (\< 2.5 mm), long lesions (\> 20 mm), ostial lesions, bifurcation lesions requesting treatment of the collateral vessel, multi-vessel disease requiring PCI before the completion of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Atorvastatin 10 mg (Type: ACTIVE_COMPARATOR): None
- Atorvastatin 80 mg (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).